alexa Nivolumab Induced Toxicity Presenting As Pneumonitis- A Case Report | OMICS International| Abstract
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Pulm Respir Med 2018, Vol 8(2): 455
  • DOI: 10.4172/2161-105X.1000455

Nivolumab Induced Toxicity Presenting As Pneumonitis- A Case Report

Vulisha AK1, Talwar A1,2, Verma S1,2,3, Gupta A4, Lam L5, Bhushan S1,6 and Singh R1,6
1Department of Pulmonary, Critical Care and Sleep Medicine, Northwell Health, , New York, USA
2Department of Heart and Lung Research, The Feinstein Institute for Medical Research, Northwell Health System, , Manhasset, New York, USA
3Touro College of Osteopathic Medicine, , New York, USA
4Advantage Care Physicians, Plainview Hospital, , New York, USA
5Department of Family Medicine, Group Glen Cove Hospital, , Glen Cove, New York, USA
6College of Osteopathic Medicine, New York Institute of Technology (NYIT), , New York, USA
*Corresponding Author :

Vulisha AK, Talwar A, Verma S, Gupta A, Lam L, Bhushan S and Singh R

Received Date: Apr 06, 2018 / Accepted Date: Apr 16, 2018 / Published Date: Apr 21, 2018


Nivolumab is a recently approved medication that shows significant clinical activity for various types of malignancies such melanoma, renal cell carcinoma and non-small cell carcinoma. Pneumonitis is a rare, but, possibly fatal manifestation that still remains ambiguous. This article presents a case of nivolumab induced pneumonitis in a patient with melanoma and discusses management plans.

Keywords: Nivolumab; Drug induced pneumonitis; Steroids; Melanoma; Checkpoint inhibitor; Crytogenic organizing pneumonia

Citation: Vulisha AK, Talwar A, Verma S, Gupta A, Lam L, et al. (2018) Nivolumab Induced Toxicity Presenting As Pneumonitis- A Case Report. J Pulm Respir Med 8: 455. Doi: 10.4172/2161-105X.1000455

Copyright: © 2018 Vulisha AK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.